Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 8/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.96 |
| ▸ | CA12 | O43570 | 6/20 | 0.96 |
| ▸ | CA9 | Q16790 | 6/20 | 0.96 |
| ▸ | HPGD | P15428 | 4/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.96 |
| ▸ | GAA | P10253 | 4/20 | 0.96 |
| ▸ | GLA | P06280 | 3/20 | 0.96 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.96 |
| ▸ | MAOB | P27338 | 3/20 | 0.96 |
| ▸ | CASP1 | P29466 | 2/20 | 0.96 |
| ▸ | CASP7 | P55210 | 2/20 | 0.96 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.96 |
| ▸ | LMNA | P02545 | 1/20 | 0.96 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.96 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.96 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.96 |
| ▸ | KDR | P35968 | 1/20 | 0.96 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hymecromone SCHEMBL29364837 | 0.98 | HSD17B3 (1.00) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL24150 | 0.98 | HSD17B3 (1.00) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL2357040 | 0.98 | HSD17B3 (1.00) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL29624431 | 0.98 | HSD17B3 (1.00) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL27924142 | 0.96 | HSD17B3 (0.96) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL27728511 | 0.95 | HSD17B3 (0.93) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL2256610 | 0.93 | ALDH1A1 (0.90) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL28882003 | 0.92 | KDM4E (0.87) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL3272842 | 0.92 | HSD17B3 (0.87) | HSD17B3ALDH1A1KDM4ECA12CA9 | |
| Hymecromone SCHEMBL7594956 | 0.92 | KDM4E (0.87) | HSD17B3ALDH1A1KDM4ECA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689352-B1 | EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN | UNIV KAOHSIUNG MEDICAL (TW) | 2023-11-15 | — | — | EP | claimed |
| US-20210205450-A1 | METHOD FOR TREATING SUBJECT SUFFERING FROM FLAVIVIRUS INFECTION | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2021-07-08 | — | — | US | claimed |
| CN-111521594-A | Novel nano-composite, preparation method thereof and application thereof in sewage detection | 重庆工程职业技术学院 | 2020-08-11 | — | — | CN | claimed |
| EP-3689352-A1 | EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN | Kaohsiung Medical University (TW) | 2020-08-05 | — | — | EP | claimed |
| US-20190107538-A1 | EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2019-04-11 | — | — | US | claimed |
| EP-3466426-A1 | EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN | Kaohsiung Medical University (TW) | 2019-04-10 | — | — | EP | claimed |
| JP-9118597-A | — | — | None | — | — | JP | disclosed |
| CN-122055148-A | Conjugates, compositions and methods for treating influenza | 珀杜研究基金会 | 2026-05-15 | — | — | CN | disclosed |
| EP-4389772-A1 | TARGETED DELIVERY OF THERAPEUTIC ENZYMES | Joint-Stock Company "Generium" (RU) | 2024-06-26 | — | — | EP | disclosed |
| CN-112534260-B | Automated liquid phase immunoreaction analysis device and method thereof | 韩国帕克特生物科技有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118019768-A | Targeted delivery of therapeutic enzymes | 吉尼瑞姆股份公司 | 2024-05-10 | — | — | CN | disclosed |
| EP-3689352-B1 | EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN | UNIV KAOHSIUNG MEDICAL (TW) | 2023-11-15 | — | — | EP | disclosed |
| US-20230305031-A1 | AUTOMATED LIQUID-PHASE IMMUNOASSAY APPARATUS | BODITECH MED INC. (KR) | 2023-09-28 | — | — | US | disclosed |
| WO-2011084703-A2 | ENZYME ASSAYS ON A DROPLET ACTUATOR | ADVANCED LIQUID LOGIC, INC. (US) | 2011-07-14 | — | — | WO | disclosed |
| EP-2325302-A1 | Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) | Shire Human Genetic Therapies, Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| EP-2325301-A1 | Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) | Shire Human Genetic Therapies, Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| US-20110118132-A1 | Enzymatic Assays Using Umbelliferone Substrates with Cyclodextrins in Droplets of Oil | ADVANCED LIQUID LOGIC, INC. (US) | 2011-05-19 | — | — | US | disclosed |
| CN-1073156-C | Novel deaminoneuraminidase and process for producing same | SEIKAGUKU KOGYO CO LTD (JP) | 2001-10-17 | — | — | CN | disclosed |
| CN-1156480-A | Novel deaminoneuraminidase and process for producing same | SEIKAGAKU KOGYO CO LTD (JP) | 1997-08-06 | — | — | CN | disclosed |
| JP-H09118597-A | CRYSTALLIZING METHOD OF MACROMOLECULE | BEHRINGWERKE AG | 1997-05-06 | — | — | JP | disclosed |